Overview

One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension

Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
A ONE YEAR SAFETY STUDY FOR PATIENTS WHO COMPLETE STUDY VAA489A2201.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Amlodipine
Amlodipine, Valsartan Drug Combination
Valsartan